DZDengfeng Zhang

Dengfeng Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Dengfeng Zhang has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Wenkai Zhou

    Department of Cardiovascular Surgery, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China

    2 shared publications
  • Caixia Sun

    The First Affiliated Hospital, Department of Emergency, Hengyang Medical School, University of South China, Hengyang, China

    1 shared publication
  • Feng Jiang

    The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University

    1 shared publication
  • Guojun Li

    Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA

    1 shared publication
  • Hailong Qiu

    Department of Cardiovascular Surgery, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China

    1 shared publication
  • Jia Xu

    Department of Cardiovascular Surgery, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China

    1 shared publication

Latest Publications

  • Open Access

    Population-specific association and risk discrimination utility of the cardiometabolic index for prevalent hypertension–diabetes comorbidity: insights from CHARLS and NHANES

    by Ting You, Jia Xu, Jukun Liu, Linhui Jiang, Zhihao Deng, Yinglan Liu, Hailong Qiu, Jia Zhou, Caixia Sun, Tianyu Chen, et al.

  • Open Access

    Causal Mediation of Immune Cells and Fatty Acids in Coronary Atherosclerosis: Insights From Mendelian Randomization Analysis

    by Yong Zhang, Jia Xu, Zhihao Deng, Xiang Long, Jukun Liu, Linhui Jiang, Nanbo Liu, Dengfeng Zhang, Wenkai Zhou, Ping Zhu

    Observational studies have suggested a link between total fatty acid levels and the development of coronary atherosclerosis. While the involvement of immune cells in the pathogenesis of this condition is well‐established, the precise causal mechanisms by which fatty acids influence immune cell function and subsequently affect coronary atherosclerosis remain unclear. To address this, we systematically assessed the causal relationships among 731 immune cell traits, circulating fatty acid levels, and coronary atherosclerosis using a two‐sample Mendelian randomization (MR) approach. Multivariable Mendelian randomization (MVMR) was further employed to investigate the potential mediating role of dendritic cells in the pathway linking fatty acids to coronary atherosclerosis. Our analysis identified significant causal associations between 30 immune cell traits and coronary atherosclerosis. Furthermore, circulating fatty acid levels were causally linked to an increased risk of coronary atherosclerosis. MVMR analysis revealed that dendritic cells, specifically the CD62L− CD86+ myeloid subset, partially mediate the causal effect of fatty acid levels on coronary atherosclerosis. This study provides genetic evidence supporting the causal roles of multiple immune cell traits and fatty acid levels in coronary atherosclerosis. Importantly, dendritic cells were identified as a key mediator in the pathway through which fatty acids influence disease risk. These findings offer new insights into the interplay between nutrition and immunity in atherosclerosis and highlight potential targets for future therapeutic and preventive strategies.

  • Open Access

    Knockdown of DDX46 Inhibits the Invasion and Tumorigenesis in Osteosarcoma Cells

    by Feng Jiang, Dengfeng Zhang, Guojun Li, Xiao Wang

    DDX46, a member of the DEAD-box (DDX) helicase family, is involved in the development of several tumors. However, the exact role of DDX46 in osteosarcoma and the underlying mechanisms in tumorigenesis remain poorly understood. Thus, in the present study, we explored the role of DDX46 in osteosarcoma and the underlying mechanisms. Our results demonstrated that the expression levels of DDX46 in both mRNA and protein were greatly elevated in human osteosarcoma tissues and cell lines. Knockdown of DDX46 obviously inhibited osteosarcoma cell proliferation and tumor growth in vivo. In addition, knockdown of DDX46 also significantly suppressed migration and invasion in osteosarcoma cells. Furthermore, knockdown of DDX46 substantially downregulated the phosphorylation levels of PI3K and Akt in SaOS2 cells. In summary, the present results have revealed that DDX46 plays an important role in osteosarcoma growth and metastasis. Knockdown of DDX46 inhibited osteosarcoma cell proliferation, migration, and invasion in vitro and tumor growth in vivo. Therefore, DDX46 may be a potential therapeutic target for the treatment of osteosarcoma.